Boston ScientificBSX stock broke out Wednesday, helped by a strong second-quarter report on the back of its high-profile ...

What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Full year adjusted EPS is now expected to be $2.95 to $2.99, representing growth of 18% to 19% versus 2024, including an approximate $0.04 headwind from foreign exchange. Third quarter adjusted EPS is ...

Jarren Duran continues to be mentioned in trade rumors; here are the three best trade destinations for the Red Sox outfielder ...

The Boston Red Sox have already been involved in a pair of trades involving All-Star talent twice since December. Now, ...

Strictly speaking, the franchise that won the bulk of Boston's titles from the founding of the organization up through the 1970s then moved to San Diego, California and later, Los Angeles, to become ...

Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Boston Scientific among financial experts is revealed through an in-depth exploration of recent analyst actions.

Outside Minneapolis, Boston Scientific has put one of its locations up for sale while expanding another nearby, according to The Minnesota Star Tribune.

Boston Scientific Corp. (NYSE: BSX) has listed its over 24-acre campus in Minnetonka for sale as it looks to move its operations to Maple Grove.

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to meet 2025 sales.